The most recent COVID-19 diagnosis and treatment program (7th edition) published by the National Health Commission of China suggested using indicators such as low lymphocyte counts, high levels of CRP, ESR, CK, AST, and LDH, and high levels of cytokines in severe patients (13). This evidence concerns the gene CRP and COVID-19.